Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
Discover what AI model collapse is, its causes, early warning signs, and severe consequences. Learn how to prevent recursive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results